Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 1
1996 1
1997 1
1998 1
2001 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
PET in breast cancer.
Flanagan FL, Dehdashti F, Siegel BA. Flanagan FL, et al. Semin Nucl Med. 1998 Oct;28(4):290-302. doi: 10.1016/s0001-2998(98)80034-2. Semin Nucl Med. 1998. PMID: 9800236 Review.
Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma.
McGuire AH, Dehdashti F, Siegel BA, Lyss AP, Brodack JW, Mathias CJ, Mintun MA, Katzenellenbogen JA, Welch MJ. McGuire AH, et al. J Nucl Med. 1991 Aug;32(8):1526-31. J Nucl Med. 1991. PMID: 1869973 Free article.
Metabolic flare: indicator of hormone responsiveness in advanced breast cancer.
Mortimer JE, Dehdashti F, Siegel BA, Trinkaus K, Katzenellenbogen JA, Welch MJ. Mortimer JE, et al. J Clin Oncol. 2001 Jun 1;19(11):2797-803. doi: 10.1200/JCO.2001.19.11.2797. J Clin Oncol. 2001. PMID: 11387350 Clinical Trial.
Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy.
Mortimer JE, Dehdashti F, Siegel BA, Katzenellenbogen JA, Fracasso P, Welch MJ. Mortimer JE, et al. Clin Cancer Res. 1996 Jun;2(6):933-9. Clin Cancer Res. 1996. PMID: 9816253 Free article.
The development of estrogen and progestin radiopharmaceuticals for imaging breast cancer.
Katzenellenbogen JA, Welch MJ, Dehdashti F. Katzenellenbogen JA, et al. Anticancer Res. 1997 May-Jun;17(3B):1573-6. Anticancer Res. 1997. PMID: 9179196
16 beta-[18F]fluoromoxestrol: a potent, metabolically stable positron emission tomography imaging agent for estrogen receptor positive human breast tumors.
VanBrocklin HF, Rocque PA, Lee HV, Carlson KE, Katzenellenbogen JA, Welch MJ. VanBrocklin HF, et al. Life Sci. 1993;53(10):811-9. doi: 10.1016/0024-3205(93)90503-u. Life Sci. 1993. PMID: 8355567
Feedback